Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 5/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.41 |
| ▸ | KARS1 | Q15046 | 1/20 | 0.40 |
| ▸ | PIM1 | P11309 | 2/20 | 0.37 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.37 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.36 |
| ▸ | TDO2 | P48775 | 1/20 | 0.36 |
| ▸ | KMO | O15229 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | ABL1 | P00519 | 1/20 | 0.34 |
| ▸ | BCR | P11274 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3423404 | 0.87 | CYP11B1 (0.49) | CYP11B2CYP11B1CYP2A6KARS1PIM1 | |
| SCHEMBL20322341 | 0.82 | CYP2A6 (0.36) | CYP2A6KARS1 | |
| SCHEMBL10001003 | 0.82 | CYP2A6 (0.61) | CYP11B2CYP11B1CYP2A6KARS1PIM1 | |
| SCHEMBL18019287 | 0.80 | KMO (0.47) | KARS1KMOKDM4E | |
| SCHEMBL28090003 | 0.79 | CYP11B2 (0.43) | CYP11B2CYP11B1CYP2A6KARS1PIM1 | |
| SCHEMBL3422003 | 0.79 | CYP2A6 (0.57) | CYP11B2CYP11B1CYP2A6KARS1PIM1 | |
| SCHEMBL16848104 | 0.74 | CYP2A6 (0.42) | CYP11B2CYP11B1CYP2A6S1PR1TDO2 | |
| SCHEMBL15750395 | 0.73 | CYP2A6 (0.62) | CYP2A6KARS1KDM4ECYP3A4ABL1 | |
| SCHEMBL3421988 | 0.72 | CYP2A6 (0.67) | CYP2A6 | |
| SCHEMBL5144659 | 0.71 | CYP2A6 (0.56) | CYP11B2CYP11B1CYP2A6KDM4ECYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11152579-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11152579-B2 | Organic electroluminescent materials and devices | CACNA2D2, RABGGTA, NUDT1 | CYP11B2 2585/4885CYP11B1 3425/4885CYP2A6 3350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.